ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE
Mark Identification

ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE

Serial Number

85063047

Filing Date

Jun 15, 2010

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Computer and Scientific
PLATINUM BLUE